• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[肾病综合征中部分先天性因子V缺乏的短暂纠正]

[Transient correction of partial congenital factor V deficiency in nephrotic syndrome].

作者信息

Monfort-Gouraud M, Leroy B, Favier R, Bensman A

机构信息

Service de néphrologie pédiatrique, hôpital Trousseau, Paris, France.

出版信息

Arch Pediatr. 1995 Feb;2(2):156-9. doi: 10.1016/0929-693x(96)89877-0.

DOI:10.1016/0929-693x(96)89877-0
PMID:7735449
Abstract

Plasma concentration of several hemostatic proteins may be modified during the acute phase of nephrotic syndrome. The case of such a syndrome in a patient with congenital factor V deficiency is presented. CASE REPORT--A 5 year-old girl with partial congenital factor V deficiency (level: 30%), was admitted for nephrotic syndrome complicating Henoch-Schönlein purpura. Urine protein excretion was 4 g/24 h. Initial plasma concentrations were: protein: 5.5 g/dl; albumin: 3.3 g/dl; factor II: 85%; factor V: 56%; factors VII + X: 80%. The patient was given methylprednisolone (1 g/1.73 m2) followed by prednisone (2 mg/kg/day). Under this treatment, the plasma concentrations were: protein: 4.5 g/dl; albumin: 2.0 g/dl; factor II: 180%; factor V: 84%; factors VII + X: 120%. Values at the onset of remission were: albumin: 3.4 g/dl; factor V: 49%. CONCLUSION--This observation suggests that hypoalbuminemia may enhance liver synthesis of factor V as known for some other coagulation factors, and transiently correct the hereditary deficiency.

摘要

在肾病综合征急性期,几种止血蛋白的血浆浓度可能会发生改变。本文报告了一名先天性因子V缺乏患者出现这种综合征的病例。病例报告——一名5岁女童,患有部分先天性因子V缺乏(水平:30%),因肾病综合征并发过敏性紫癜入院。尿蛋白排泄量为4g/24小时。初始血浆浓度为:蛋白质:5.5g/dl;白蛋白:3.3g/dl;因子II:85%;因子V:56%;因子VII + X:80%。给予患者甲泼尼龙(1g/1.73m²),随后给予泼尼松(2mg/kg/天)。在这种治疗下,血浆浓度为:蛋白质:4.5g/dl;白蛋白:2.0g/dl;因子II:180%;因子V:84%;因子VII + X:120%。缓解开始时的值为:白蛋白:3.4g/dl;因子V:49%。结论——该观察结果表明,低白蛋白血症可能会增强肝脏对因子V的合成,就像其他一些凝血因子一样,并暂时纠正遗传性缺乏。

相似文献

1
[Transient correction of partial congenital factor V deficiency in nephrotic syndrome].[肾病综合征中部分先天性因子V缺乏的短暂纠正]
Arch Pediatr. 1995 Feb;2(2):156-9. doi: 10.1016/0929-693x(96)89877-0.
2
[Complete remission of nephrotic syndrome with methylprednisolone pulses in an adult with Schönlein-Henoch purpura].[成人过敏性紫癜患者应用甲泼尼龙冲击治疗后肾病综合征完全缓解]
Nefrologia. 2007;27(1):96-8.
3
Severe nephrotic syndrome in a patient with Schönlein-Henoch purpura: complete remission after cyclosporin A.一名过敏性紫癜患者出现严重肾病综合征:环孢素A治疗后完全缓解
Nephrol Dial Transplant. 1997 Apr;12(4):790-2. doi: 10.1093/ndt/12.4.790.
4
Successful treatment of adult-onset Henoch-Schönlein purpura nephritis with high-dose immunoglobulins.
Intern Med. 1999 Apr;38(4):376-9. doi: 10.2169/internalmedicine.38.376.
5
A novel mutation of congenital factor V deficiency in Henoch-Schönlein purpura.过敏性紫癜中先天性因子V缺乏的一种新突变。
Pediatr Int. 2020 Aug;62(8):1005-1006. doi: 10.1111/ped.14229.
6
Rifampin therapy in Henoch-Schönlein purpura nephritis accompanied by nephrotic syndrome.利福平治疗伴肾病综合征的过敏性紫癜性肾炎。
Child Nephrol Urol. 1988;9(1-2):50-6.
7
A large intracardiac thrombus in a child with steroid-resistant nephrotic syndrome.一名患有激素抵抗型肾病综合征儿童的心脏内巨大血栓。
Cardiol Young. 2013 Jun;23(3):440-2. doi: 10.1017/S1047951112000923. Epub 2012 Jul 20.
8
Cyclosporine A for heavy proteinuria in a child with Henoch-Schönlein purpura nephritis.环孢素A治疗一名过敏性紫癜性肾炎患儿的重度蛋白尿
Pediatr Int. 2004 Feb;46(1):111-3. doi: 10.1111/j.1328-0867.2004.01842.x.
9
Clinical outcomes in children with Henoch-Schönlein purpura nephritis without crescents.无新月体的过敏性紫癜性肾炎患儿的临床结局
Pediatr Nephrol. 2017 Jul;32(7):1193-1199. doi: 10.1007/s00467-017-3604-9. Epub 2017 Feb 15.
10
The treatment of severe glomerulopathies in children using high dose intravenous methylprednisolone pulses.大剂量静脉注射甲基强的松龙冲击治疗儿童重症肾小球疾病
Am J Kidney Dis. 1981 Nov;1(3):148-56. doi: 10.1016/s0272-6386(81)80021-2.